Cancer Risk Increased With Recent Weight Loss
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, Jan. 26, 2024 -- Individuals with recent weight loss have a significantly increased risk for cancer during the subsequent 12 months, according to a study published online in the Jan. 23/30 issue of the Journal of the American Medical Association.
Qiao-Li Wang, M.D., Ph.D., from Harvard Medical School in Boston, and colleagues examined the rates of subsequent cancer diagnoses over 12 months among health professionals with weight loss during the prior two years compared with those without recent weight loss. The prospective cohort analysis consisted of women aged 40 years and older from the Nurses' Health Study and men aged 40 years and older from the Health Professionals Follow-Up Study.
The researchers identified 15,809 incident cancer cases during 1.64 million person-years of follow-up among 157,474 participants (incident rate, 964 cases/100,000 person-years). During the 12 months after reported weight change, there were 1,362 and 869 cancer cases/100,000 person-years among those with recent weight loss of greater than 10 percent of body weight and those without recent weight loss, respectively (between-group difference, 493 cases/100,000 person-years). Among participants characterized with low intentionality for weight loss, there were 2,687 and 1,220 cancer cases/100,000 person-years among those with weight loss of greater than 10.0 percent of body weight and those without recent weight loss, respectively (between-group difference, 1,467 cases/100,000 person-years). Among participants with recent weight loss, cancer of the upper gastrointestinal tract was particularly common.
"Although cancer risk was higher in participants with recent weight loss, many individual cancer types, including breast, genital, urinary, brain, and melanoma, were not associated with recent weight loss," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-01-27 06:15
Read more
- Winter's Onset Brings Mood Changes to Many Americans, Poll Finds
- Neurogene Reports Positive Interim Efficacy Data from First Four Low-Dose Pediatric Participants in NGN-401 Gene Therapy Clinical Trial for Rett Syndrome
- AHA: Obesity-Linked Ischemic Heart Disease Mortality Increasing in U.S.
- Quitting Smoking After Cancer Diagnosis Boosts Survival by Up to 26%
- Expanding Access to Obesity Medications Could Avert 42,000 Deaths/Year
- Lexicon Announces Outcome of FDA Advisory Committee for Zynquista (sotagliflozin) as an Adjunct to Insulin Therapy for Glycemic Control in Adults with Type 1 Diabetes and Chronic Kidney Disease
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions